RE: Question for LT Holders14 Feb 2021 23:05
Hi MIKODX,
Cytiva produce 10,000 RT-PCR Beads/hr, or 160,000 in a double 8hr shift/day = 1,120,000 if working 7days/week, I bead = 1 RT-PCR Test !
It was also said that Cytiva could increase their Manufacturing capacity, if need be - eg double up their Production Equipment ?!
Some Conservative Numbers to consider: !
GDR Valuation of COVID Tests:
Extract from my post on 12th Sept: - GDR Potential: -
I believe that GDR Mcap is potentially worth £300 mil Mcap, based on projected Sales and Profit.
I expect GDR to sell at least 50,000 RT-PCR Test units/day at £10 per Test = £500,000 per day revenue at 60% profit margin = £300,000 per day profit.
Working on a 5 day week = 5 x £300,000 = £1,500,000 profit per week.
£1,500,000 x 50 wks per year = £75,000,000 profit per year.
Using a standard multiple of 4 for valuation = 4 x £75,000,000 = Mcap of £300,000,000
Mcap of £300,000,000 divided by 52,000,000 shares = a potential SP of £5.77p
I need to change my calculation now, due to increase in GDR Total Shares in market:
Therefore - £300,000,000 divided by 56,464,752 shares = a potential £5.31 SP !
Taking into consideration BGF conversion of their Loan Note to Shares, means our Total Share in Market will rise to 64,000,000 Shares.
Therefore - £300,000,000 divided by 64,000,000 shares = a potential £4.68p SP !
A build up to sell 50,000 RT-PCR Test units/day, is on the conservative side IMO !
'This Mcap valuation did not take into consideration a valuation of our POC; HCV OR AIHL etc'
Africa; India and USA are our Targeted Markets, and this is why DB has cleverly chosen these markets:
More recently it has been said that BC will Target USA, and Europe too !
Population of Africa 2020 = 1,348,301,517
Population of India 2020 = 1,380,004,385
Population of USA 2020 = 331,000,000
Population of Europe is 747,911,496
Massive new cases and deaths in Africa; India and USA, and these Countries will need GDR/BC Tests ! -we have a quality Product, that can Help ! - with more to come !
COVID Tests will be needed for many years to come, way past COVID Vaccine World wide availability, IMHO.